Literature DB >> 25045796

Serum anti-Müllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China.

Xuanxuan Tian1, Xiangyan Ruan, Alfred O Mueck, Diethelm Wallwiener, Juan Wang, Shunyu Liu, Dongmei Yin, Yongjun Lu, Ying Zhang, Hongqin Wu.   

Abstract

OBJECTIVES: Objective was to evaluate anti-Müllerian-hormone (AMH) and parameters for insulin resistance (IR) in the main phenotypes of polycystic ovarian syndrome (PCOS), and to investigate their correlation for the first time in non-obese Chinese women.
METHODS: Within this prospective study, 160 PCOS cases and 40 healthy women, matched by age and BMI, were included. In four groups (n = 40) according to the four phenotypes of PCOS by definition of the National Institute of Health (2012), AMH, ovarian volume and number of follicles 2-9 mm were assessed as well as insulin resistance indexes (Homeostatic Model Assessment) (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI).
RESULTS: AMH levels were higher in PCOS than in controls, with differences comparing the phenotypes, highest in the group with all three criteria for PCOS. However, for HOMA-IR and QUICKI and correlation to AMH no significant differences were found.
CONCLUSIONS: AMH is a useful parameter to assess in the different phenotypes the severity of PCOS, and to compare with healthy women, for the first time demonstrated in Chinese patients. In contrast, the parameters for IR and their relation to AMH did not show clear differences comparing the four phenotypes, and need further investigation.

Entities:  

Keywords:  Anti-Müllerian hormone; insulin resistance; polycystic ovarian syndrome

Mesh:

Substances:

Year:  2014        PMID: 25045796     DOI: 10.3109/09513590.2014.943719

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  6 in total

1.  Associations Between Anti-Mullerian Hormone and Cardiometabolic Health in Reproductive Age Women Are Explained by Body Mass Index.

Authors:  Julie S Rios; Eleni A Greenwood; Mary Ellen G Pavone; Marcelle I Cedars; Richard S Legro; Michael P Diamond; Nanette Santoro; Fangbai Sun; Randal D Robinson; Gregory Christman; Heping Zhang; Heather G Huddleston
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

2.  It's Never over until It's over: How Can Age and Ovarian Reserve Be Mathematically Bound through the Measurement of Serum AMH-A Study of 5069 Romanian Women.

Authors:  Bogdan Doroftei; Cristina Mambet; Mihaela Zlei
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

Review 3.  Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress.

Authors:  Awadhesh Kumar Singh; Ritu Singh
Journal:  Indian J Endocrinol Metab       Date:  2015 Nov-Dec

4.  The correlation between serum AMH and HOMA-IR among PCOS phenotypes.

Authors:  Budi Wiweko; Indra Indra; Cynthia Susanto; Muharam Natadisastra; Andon Hestiantoro
Journal:  BMC Res Notes       Date:  2018-02-09

5.  Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome.

Authors:  Juan Du; Xiangyan Ruan; Fengyu Jin; Yanglu Li; Jiaojiao Cheng; Muqing Gu; Alfred Otto Mueck
Journal:  J Ovarian Res       Date:  2021-02-18       Impact factor: 4.234

6.  Correlation of Homeostatic Model Assessment-Insulin Resistance, Anti-Mullerian Hormone, and BMI in the Characterization of Polycystic Ovary Syndrome.

Authors:  Anupama Bahadur; Neha Verma; Rajlaxmi Mundhra; Latika Chawla; Megha Ajmani; Modalavalasa Swetha Sri; Shivaani Arora
Journal:  Cureus       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.